Therapy used to promote disease remission targeting gut dysbiosis, in uc patients with active disease

HIGHLIGHTS

• who: Hengameh Chlou00e8 Mirsepasi-Lauridsen from the (UNIVERSITY) have published the article: Therapy Used to Promote Disease Remission Targeting Gut Dysbiosis, in UC Patients with Active Disease, in the Journal: (JOURNAL)
• what: The aim of this study is to investigate the innovative treatment method used to promote disease in UC patients with active disease Immunosuppressants such as TNF-u03b1 blocker are used to promote disease in UC but it is expensive and with side effects. The studies show that nutritional therapy with prebiotic properties enables modulation of the gut microbiota and regulation of the immune . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.